Manish R. Patel, Benedito A. Carneiro, Jean-Pierre Delord, Johann S. de Bono, Christian Ostheimer, Kentaro Ito, Yuichi Takahashi, Di Shu, Nasser Khan, Antonio Tito Fojo, Karim Olivier Fizazi. "A phase 1, first-in-human study of DS9051, a novel targeted protein degradation molecule, in patients with advanced/metastatic adrenocortical carcinoma (ACC) or metastatic castration-resistant prostate cancer (mCRPC).." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.tps3179